Newtyn Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Newtyn Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $82,950 - $123,300	-15,000 Reduced 12.5%	105,000 $641,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $84,300 - $150,000	15,000 Added 14.29%	120,000 $766,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $669,900 - $1.92 Million	105,000 New	105,000 $1.16 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Newtyn Management, LLC with notifications on news.